Related references
Note: Only part of the references are listed.Circadian robustness as an independent predictor of prolonged progression-free survival (PFS) and overall survival (OS) in 436 patients with metastatic colorectal cancer (mCRC).
Francis Levi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Sex and Dosing-Time Dependencies in Irinotecan-Induced Circadian Disruption
Constance Ahowesso et al.
CHRONOBIOLOGY INTERNATIONAL (2011)
Recent trends in colorectal cancer mortality in Europe
Cristina Bosetti et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Sex difference in the near-24-hour intrinsic period of the human circadian timing system
Jeanne F. Duffy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Chronotherapy and the molecular clock: Clinical implications in oncology
Pasquale F. Innominato et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Circadian Timing in Cancer Treatments
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Xiao-Mei Li et al.
CANCER RESEARCH (2010)
Sex Differences in Phase Angle of Entrainment and Melatonin Amplitude in Humans
Sean W. Cain et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2010)
Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy
Ann M. Berger et al.
SUPPORTIVE CARE IN CANCER (2010)
A New Integrated Variable Based on Thermometry, Actimetry and Body Position (TAP) to Evaluate Circadian System Status in Humans
Elisabet Ortiz-Tudela et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer
Pasquale F. Innominato et al.
CANCER RESEARCH (2009)
Circadian Clock Manipulation for Cancer Prevention and Control and the Relief of Cancer Symptoms
William J. M. Hrushesky et al.
INTEGRATIVE CANCER THERAPIES (2009)
Circadian Disruption, Fatigue, and Anorexia Clustering in Advanced Cancer Patients: Implications for Innovative Therapeutic Approaches
Pasquale F. Innominato et al.
INTEGRATIVE CANCER THERAPIES (2009)
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer
Cathy Eng
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Breast Cancer Patients have Progressively Impaired Sleep-Wake Activity Rhythms during Chemotherapy
Josee Savard et al.
SLEEP (2009)
Symptom clusters in patients with advanced cancers
Winson Y. Cheung et al.
SUPPORTIVE CARE IN CANCER (2009)
Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy
Giuseppe Aprile et al.
CANCER (2008)
Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer
Andrew H. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Methodological challenges when using actigraphy in research
Ann M. Berger et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2008)
A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue
Ollie Minton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Molecular epidemiology, cancer-related symptoms, and cytokines pathway
Cielito C. Reyes-Gibby et al.
LANCET ONCOLOGY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Cytokines and their relationship to the symptoms and outcome of cancer
Bostjan Seruga et al.
NATURE REVIEWS CANCER (2008)
Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia
Marita Fouladiun et al.
CLINICAL CANCER RESEARCH (2007)
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics
Francis Levi et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Symptom prevalence in patients with incurable cancer: A systematic review
Saskia C. C. M. Teunissen et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer
Ida Iurisci et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Jet lag: trends and coping strategies
Jim Waterhouse et al.
LANCET (2007)
Circadian rhythms: Mechanisms and therapeutic implications
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2007)
Symptom clustering in advanced cancer
Declan Walsh et al.
SUPPORTIVE CARE IN CANCER (2006)
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer:: The European Organisation for Research and Treatment of Cancer Chronotherapy group
Sylvie Giacchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Systematic review of the treatment of cancer-associated anorexia and weight loss
T Yavuzsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The rhythm of rest and excess
RG Foster et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Effects of light and food schedules on liver and tumor molecular clocks in mice
E Filipski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer
T Rich et al.
CLINICAL CANCER RESEARCH (2005)
Fatigue in cancer patients receiving chemotherapy: an analysis of published studies
A Iop et al.
ANNALS OF ONCOLOGY (2004)
Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?
S Sephton et al.
BRAIN BEHAVIOR AND IMMUNITY (2003)
The role of actigraphy in the study of sleep and circadian rhythms
S Ancoli-Israel et al.
SLEEP (2003)
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo
LN Fu et al.
CELL (2002)
Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment
JA Roscoe et al.
SUPPORTIVE CARE IN CANCER (2002)
Contribution of the rest-activity circadian rhythm to quality of life in cancer patients
MC Mormont et al.
CHRONOBIOLOGY INTERNATIONAL (2002)
Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice
XM Li et al.
CHRONOBIOLOGY INTERNATIONAL (2002)
Share Paper
